138 Epizód

  1. Ustekinumab and Vedolizumab Demonstrate Safety During Pregnancy: Updates from the PIANO Registry

    Közzétéve: 2024. 04. 24.
  2. When to Discontinue Colorectal Cancer Screening in Older Adults: Chronological Age or Life Expectancy?

    Közzétéve: 2024. 03. 20.
  3. ICYMI: Eating “Healthy” to Minimize Colon Cancer

    Közzétéve: 2024. 03. 20.
  4. ICYMI: How Frequently Should We Perform Colonoscopy in Patients with Serrated Polyposis Syndrome?

    Közzétéve: 2024. 03. 20.
  5. ESD vs EMR for Large Non-Pedunculated Colon Polyps: Fewer Recurrences but More Complications

    Közzétéve: 2024. 03. 20.
  6. Continued Treatment With Tirzepatide Is Necessary to Maintain Weight Loss

    Közzétéve: 2024. 02. 21.
  7. Add Prophylactic Pancreatic Duct Stents to Rectal Indomethacin to Minimize Post-ERCP Pancreatitis in High-Risk Patients

    Közzétéve: 2024. 02. 21.
  8. Non-Erosive GERD Does Not Lead to an Increased Risk of Esophageal Adenocarcinoma

    Közzétéve: 2024. 02. 21.
  9. Making Bowel Preparation Palatable: Efficacy of a Novel Sports Drink Flavor-Optimized PEG and Sulfate Bowel Preparation

    Közzétéve: 2024. 02. 21.
  10. Post-Colonoscopy Colorectal Cancer Due to Missed Polyps in Proximal Colon or Rectum with Sub-Optimal Bowel Cleansing

    Közzétéve: 2024. 01. 17.
  11. Mirikizumab Is Effective for Induction and Maintenance of Ulcerative Colitis

    Közzétéve: 2024. 01. 17.
  12. Is Early Ileocecal Resection for Crohn’s Disease An Appropriate Primary Treatment?

    Közzétéve: 2024. 01. 17.
  13. Which Endoscopists Benefit from Using Computer-Aided Detection of Polyps During Colonoscopy?

    Közzétéve: 2024. 01. 17.
  14. ICYMI: Lynch Syndrome-An Aspirin a Day Keeps Colorectal Cancer Away!

    Közzétéve: 2023. 12. 13.
  15. Low-dose Tricyclic Antidepressants for Irritable Bowel Syndrome: Definitive Evidence of Benefit from ATLANTIS

    Közzétéve: 2023. 12. 13.
  16. Overt Evidence for the Efficacy and Safety of Thalidomide in Gastrointestinal Bleeding from Small Intestinal Angiodysplasia

    Közzétéve: 2023. 12. 13.
  17. Hepatocellular Carcinoma Incidence Rates Are 2%-3% in US Patients with Cirrhosis Regardless of Etiology

    Közzétéve: 2023. 12. 13.
  18. Etrasimod, a Sphingosine 1-Phosphate Receptor Modulator, for Moderate-Severe Ulcerative Colitis: New Options for Oral Therapy

    Közzétéve: 2023. 11. 15.
  19. Post-Endoscopy Esophageal Adenocarcinoma: Take a PEEC at Endoscopy Quality in Barrett's Esophagus

    Közzétéve: 2023. 11. 15.
  20. Surveillance of Branch Duct IPMN – Enough is Enough, At Least in Older Adults and Small, Stable Lesions

    Közzétéve: 2023. 11. 15.

3 / 7

A new monthly publication from the American College of Gastroenterology, Evidence-Based GI (EBGI) uses evidence-based methods to create abstracts and explain study results of new and important articles in the field of gastroenterology and hepatology. Listen as editors of EBGI discuss the articles they review and how the recommendations can be applied to your practice.

Visit the podcast's native language site